Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lidia Ruiz

Showing results (121-130 of 164) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
Immunology|April 20, 2011
The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responsesMontserrat Plana, Felipe Garcia, Laila Darwich, et al.
Immunology|September 2, 2008
Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18Laila Darwich, Gemma Coma, Ruth Peña, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
The Lancet. Infectious Diseases|May 30, 2021
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trialBoris Revollo, Ignacio Blanco, Pablo Soler, et al.
Computational and Structural Biotechnology Journal|January 29, 2021
Unveiling the dimer/monomer propensities of Smad MH1-DNA complexesLidia Ruiz, Zuzanna Kaczmarska, Tiago Gomes, et al.
The Journal of General Virology|July 18, 2003
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapyJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppressionEugenia Negredo, Luís Cruz, Roger Paredes, et al.
Oncology Letters|October 11, 2021
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectivesLeonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, et al.
AIDS (London, England)|October 17, 2018
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapyAnna Schultze, Carlo Torti, Alessandro Cozzi-Lepri, et al.
Pageof 17

Showing results (121-130 of 164) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|October 24, 2007
Impact of HIV-1 reverse transcriptase polymorphism F214L on virological response to thymidine analogue-based regimens in antiretroviral therapy (ART)-naive and ART-experienced patientsFrancesca Ceccherini-Silberstein, Alessandro Cozzi-Lepri, Lidia Ruiz, et al.
Immunology|April 20, 2011
The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responsesMontserrat Plana, Felipe Garcia, Laila Darwich, et al.
Immunology|September 2, 2008
Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18Laila Darwich, Gemma Coma, Ruth Peña, et al.
Annals of Internal Medicine|July 16, 2003
Alternation of antiretroviral drug regimens for HIV infection. A randomized, controlled trialJavier Martinez-Picado, Eugènia Negredo, Lidia Ruiz, et al.
The Lancet. Infectious Diseases|May 30, 2021
Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trialBoris Revollo, Ignacio Blanco, Pablo Soler, et al.
Computational and Structural Biotechnology Journal|January 29, 2021
Unveiling the dimer/monomer propensities of Smad MH1-DNA complexesLidia Ruiz, Zuzanna Kaczmarska, Tiago Gomes, et al.
The Journal of General Virology|July 18, 2003
A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapyJan Weber, Hector R Rangel, Bikram Chakraborty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2002
Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppressionEugenia Negredo, Luís Cruz, Roger Paredes, et al.
Oncology Letters|October 11, 2021
Towards an updated view on the clinical management of pancreatic adenocarcinoma: Current and future perspectivesLeonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, et al.
AIDS (London, England)|October 17, 2018
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapyAnna Schultze, Carlo Torti, Alessandro Cozzi-Lepri, et al.
Pageof 17